Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

NeoStem Raises $11 Million from Asian Investors

publication date: Apr 13, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

NeoStem, Inc. raised $11 million from a private placement with Asian investors. Much of the money will be spent to increase the company’s China operations. In November 2008, NeoStem gained control over a China regenerative medical therapy company, Shandong New Medicine Research Institute of Integrated Traditional and Western Medicine LLC. NeoStem says it will expand its medical tourism business, offering regenerative therapies that are not available in the West. More details...

Stock Symbol: (AMEX: NBS)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners